Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Abstract Text:

Stefano Luminari,Marina Cesaretti,Ivan Rashid,Caterina Mammi,Antonella Montanini,Elisa Barbolini,Monica Bellei,Elsa Pennese,Maria Angela Sirotti,Luigi Marcheselli,Giovanni Partesotti,Alessia Bari,Antonino Maiorana,Goretta Bonacorsi,Massimo Federico,Stefano Luminari,Marina Cesaretti,Ivan Rashid,Caterina Mammi,Antonella Montanini,Elisa Barbolini,Monica Bellei,Elsa Pennese,Maria Angela Sirotti,Luigi Marcheselli,Giovanni Partesotti,Alessia Bari,Antonino Maiorana,Goretta Bonacorsi,Massimo Federico,

We conducted a population-based study of peripheral lymphomas (PL) that had been diagnosed between 1997 and 2003 in the province of Modena, Italy, with the aim of providing updated incidence, clinical and survival data for these cancers. We evaluated the incidence patterns and time trends of 1582 cases of PL that had been reclassified according to the WHO classification of hematological malignancies. Data regarding clinical characteristics, treatment and outcome were also collected for each case. The World Age-Standardized Rate (ASR) was calculated as 13.4, 2.2 and 3.4 per 100,000 people for B-cell non-Hodgkin's lymphoma (NHL), T-cell NHL and Hodgkin's Lymphoma (HL), respectively, with an increase of 1.62% per year during the study period. The lymphoma subtype showing the highest incidence was found to be diffuse large B-cell lymphoma (DLBCL) with an ASR of 4.8. Compared with reports from other western countries, our series is characterized by a higher incidence of HL and indolent B-NHL in general, and of CLL/SLL (ASR = 3.3) and marginal zone NHL (ASR = 1.5), in particular, and also by a lower incidence of FL (ASR = 2). After a median follow-up of 54 months, the 5-year relative survival for the whole series was found to be 70% with a statistically significant improvement for cases diagnosed during 2002-2003 (from 66 to 74%; p = 0.03). Survival improvement within the study period was also evident for patients with DLBCL, HL and T-NHL. Our study provides a comprehensive description of both the epidemiological and clinical features of PL cases in Modena and our data also reflect the major advances in the curability of some histological subtypes of this disease. The usefulness of a population-based approach to better characterizing different lymphoma subtypes is also demonstrated. Copyright (c) 2007 John Wiley & Sons, Ltd.

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Publishing Authors By Initials

S Luminari,M Cesaretti,I Rashid,C Mammi,A Montanini,E Barbolini,M Bellei,E Pennese,MA Sirotti,L Marcheselli,G Partesotti,A Bari,A Maiorana,G Bonacorsi,M Federico,S Luminari,M Cesaretti,I Rashid,C Mammi,A Montanini,E Barbolini,M Bellei,E Pennese,MA Sirotti,L Marcheselli,G Partesotti,A Bari,A Maiorana,G Bonacorsi,M Federico,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hematological oncology

VOLUME: 25

Page Numbers: 189-97

Journal Abbreviation:

ISSN: 0278-0232

DAY: 10

MONTH: Dec

YEAR: 2007

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8307268

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.

AFFILIATION: Dipartimento di Oncologia ed Ematologia, Università di Modena e Reggio Emilia, Modena, Italy.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hematol Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy Related Publications

• A case of dystonia with onset during pregnancy.
• A case of ovarioleukodystrophy without eIF2B mutations.
• A new case of short-chain acyl-CoA dehydrogenase deficiency: clinical, biochemical, genetic and (1)H-NMR spectroscopic studies.
• A novel heteroplasmic tRNA(Ser(UCN)) mtDNA point mutation associated with progressive external ophthalmoplegia and hearing loss.
• Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene.
• De novo double translocation 3;13 and 4;8;18 in a patient with mental retardation and skeletal abnormalities.
• Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke.
• Estimating survival in newly diagnosed cancer patients: Use of computer simulations to evaluate performances of different approaches in a wide range of scenarios.
• Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
• Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele.
• High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma.
• Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.
• Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
• Increase of serum levels of vitamin E during human aging: Is it a protective factor against death?
• Increased lung surfactant phosphatidylcholine in patients affected by lysosomal storage diseases.
• MR brain imaging of fucosidosis type I.
• Microvascular impairment is associated with insulin resistance in euglycemic mild hypertensives.
• Minimally invasive esophagectomy: a teaching hospital's first year experience.
• Motor-sensory neuropathy without minifascicles in a patient with 46XY gonadal dysgenesis.
• Muscle respiratory chain enzyme activities in parkinson's disease and in multisystem extrapyramidal disorders with parkinsonism as the main clinical feature.
• Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation.
• Preventing harm from high-alert medications.
• Recurrent venous thrombosis including cerebral venous sinus thrombosis in a patient taking sildenafil for erectile dysfunction.
• Renal transplantation and sleep: a new life is not enough.
• Retinochoroidal atrophy in two adult patients with Angelman syndrome.
• The first cerebrotendinous xanthomatosis family from Argentina: a new mutation in CYP27A1 gene.
• The use of the Novosol process for the treatment of polluted marine sediment.
• [Hunter's disease: genetic, clinical and biochemical study of a new family]
• [Ordinary hospitalisation, day surgery and one-day surgery: appropriateness and economic considerations in the DRG era]
• [The dentist and anti-inflammatory agents]